Inhibition of IκB Kinase Attenuates the Organ Injury and Dysfunction Associated with Hemorrhagic Shock.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4607620)

Published in Mol Med on June 18, 2015

Authors

Regina Sordi1,2, Fausto Chiazza3, Florence L Johnson1, Nimesh S A Patel1, Karim Brohi4, Massimo Collino3, Christoph Thiemermann1

Author Affiliations

1: The William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom.
2: Capes Foundation, Ministry of Education of Brazil, Brasilia, DF, Brazil.
3: University of Turin, Department of Drug Science and Technology, Turin, Italy.
4: Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom.

Articles cited by this

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature (1997) 11.31

The global burden of injuries. Am J Public Health (2000) 8.32

A genomic storm in critically injured humans. J Exp Med (2011) 6.67

Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation (2000) 4.96

The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev (1993) 4.93

Interleukin 10 protects mice from lethal endotoxemia. J Exp Med (1993) 4.46

The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem (2002) 4.28

Possible new role for NF-kappaB in the resolution of inflammation. Nat Med (2001) 3.53

Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med (1991) 2.76

Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med (2002) 2.27

The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock. Crit Care Med (2012) 2.17

Postinjury multiple organ failure. Injury (2009) 1.97

Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci U S A (1993) 1.96

Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci U S A (1994) 1.83

A 12-year prospective study of postinjury multiple organ failure: has anything changed? Arch Surg (2005) 1.80

Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation (2004) 1.52

Akt is a downstream target of NF-kappa B. J Biol Chem (2002) 1.43

Current theories on the pathophysiology of multiple organ failure after trauma. Injury (2010) 1.42

IKK biology. Immunol Rev (2012) 1.40

Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (Review). Int J Mol Med (1999) 1.39

Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology (1995) 1.37

Heparin in inflammation: potential therapeutic applications beyond anticoagulation. Adv Pharmacol (1999) 1.34

The IκB kinase complex in NF-κB regulation and beyond. EMBO Rep (2013) 1.32

Quantitation of ICAM-1 expression in mouse lung during pneumonia. J Immunol (1994) 1.31

Modulating leukocyte recruitment in inflammation. J Allergy Clin Immunol (2007) 1.30

Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock. FASEB J (2001) 1.23

It takes two to tango: IκBs, the multifunctional partners of NF-κB. Immunol Rev (2012) 1.17

Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis. J Immunol (2012) 1.16

Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock (2004) 1.12

Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am J Respir Crit Care Med (2003) 1.11

Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats. Crit Care (2010) 1.08

Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock. Crit Care Med (2008) 1.06

The PI3K/Akt pathway mediates the nongenomic cardioprotective effects of estrogen following trauma-hemorrhage. Ann Surg (2007) 1.03

Significance of TNF in hemorrhage-related hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol (1997) 1.03

Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis. Immunobiology (2011) 1.01

Internalin B activates nuclear factor-kappa B via Ras, phosphoinositide 3-kinase, and Akt. J Biol Chem (2001) 0.97

The phosphatidylinositol 3-kinase/Akt pathway negatively regulates Nod2-mediated NF-kappaB pathway. Biochem Pharmacol (2008) 0.96

A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock. Mol Med (2011) 0.94

An exogenous hydrogen sulphide donor, NaHS, inhibits the nuclear factor κB inhibitor kinase/nuclear factor κb inhibitor/nuclear factor-κB signaling pathway and exerts cardioprotective effects in a rat hemorrhagic shock model. Biol Pharm Bull (2012) 0.94

Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse. Dis Model Mech (2013) 0.93

Late, but not early, inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model. J Pharmacol Exp Ther (2008) 0.93

A novel, potent and selective inhibitor of the activity of inducible nitric oxide synthase (GW274150) reduces the organ injury in hemorrhagic shock. J Physiol Pharmacol (2002) 0.92

Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury. Mol Med (2012) 0.91

Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway. J Mol Cell Cardiol (2005) 0.91

Exogenous hydrogen sulfide protects against traumatic hemorrhagic shock via attenuation of oxidative stress. J Surg Res (2011) 0.90

Influence of selective nitric oxide synthetase inhibitor for treatment of refractory haemorrhagic shock. Resuscitation (2004) 0.89

Inhibition of hypoxia inducible factor-1α ameliorates lung injury induced by trauma and hemorrhagic shock in rats. Acta Pharmacol Sin (2012) 0.88

Role of alveolar macrophages in the inflammatory response after trauma. Shock (2014) 0.88

Eritoran attenuates tissue damage and inflammation in hemorrhagic shock/trauma. J Surg Res (2013) 0.87

Improvement of ventilation-induced lung injury in a rodent model by inhibition of inhibitory κB kinase. J Trauma Acute Care Surg (2014) 0.87

Immunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation. J Immunol (2014) 0.82

Pneumonia-induced sepsis in mice: temporal study of inflammatory and cardiovascular parameters. Int J Exp Pathol (2013) 0.81

Dual role of lipoxin A4 in pneumosepsis pathogenesis. Int Immunopharmacol (2013) 0.81

Early potassium channel blockade improves sepsis-induced organ damage and cardiovascular dysfunction. Br J Pharmacol (2011) 0.80

Hnf-1β transcription factor is an early hif-1α-independent marker of epithelial hypoxia and controls renal repair. PLoS One (2013) 0.80

Hydrocortisone prevents immunosuppression by interleukin-10+ natural killer cells after trauma-hemorrhage. Crit Care Med (2014) 0.80

Delayed neutralization of interleukin 6 reduces organ injury, selectively suppresses inflammatory mediator, and partially normalizes immune dysfunction following trauma and hemorrhagic shock. Shock (2014) 0.79

The role of the IKK complex in viral infections. Pathog Dis (2014) 0.79

'Preconditioning' with low dose lipopolysaccharide aggravates the organ injury / dysfunction caused by hemorrhagic shock in rats. PLoS One (2015) 0.78

Effect of ICAM-1 blockade on lung inflammation and physiology during acute viral bronchiolitis in rats. Pediatr Res (2000) 0.78

Heat-shock response increases lung injury caused by Pseudomonas aeruginosa via an interleukin-10-dependent mechanism in mice. Anesthesiology (2014) 0.77